BIOORGANIC & MEDICINAL CHEMISTRY

期刊名
BIOORGANIC & MEDICINAL CHEMISTRY

BIOORGAN MED CHEM

ISSN / eISSN
0968-0896 / 1464-3391
目标和范围
Bioorganic & Medicinal Chemistry provides an international forum for the publication of full original research papers and critical reviews on molecular interactions in key biological targets such as receptors, channels, enzymes, nucleotides, lipids and saccharides.

The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. A special feature will be that colour illustrations will be reproduced at no charge to the author, provided that the Editor agrees that colour is essential to the information content of the illustration in question.
研究方向

有机化学

生化与分子生物学

药物化学

CiteScore
6.80 查看趋势图
CiteScore 学科排名
类别 分区 排名
Pharmacology, Toxicology and Pharmaceutics - Pharmaceutical Science Q1 #45/183
Pharmacology, Toxicology and Pharmaceutics - Organic Chemistry Q2 #55/211
Pharmacology, Toxicology and Pharmaceutics - Clinical Biochemistry Q2 #36/117
Pharmacology, Toxicology and Pharmaceutics - Drug Discovery Q2 #50/157
Pharmacology, Toxicology and Pharmaceutics - Biochemistry Q2 #149/438
Pharmacology, Toxicology and Pharmaceutics - Molecular Medicine Q2 #69/178
Pharmacology, Toxicology and Pharmaceutics - Molecular Biology Q2 #172/410
Web of Science 核心收藏夹
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
类别 (Journal Citation Reports 2024) 分区
BIOCHEMISTRY & MOLECULAR BIOLOGY Q2
CHEMISTRY, MEDICINAL Q2
CHEMISTRY, ORGANIC Q1
H-index
142
出版国家或地区
ENGLAND
出版商
Elsevier Ltd
出版周期
Semimonthly
出版年份
1993
年文章数
238
Open Access
NO
通讯方式
PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OX5 1GB
认证评论
注: 认证评论选取于全球各个学术评论平台和社交媒体。
4.8 submission, 5.16 first-round revision, 6.8 final revision, 6.20 acceptance. The revised version did not include additional experiments, but all the reviewer's comments were diligently addressed. The revision took longer due to the vacation and the pandemic of our overseas collaborators. BMC is relatively more classic, but in the past two years, medical journals have been rapidly rising, and BMC has not benefitted from this trend. Those working on tuberculosis can refer to our article 10.1016/j.bmc.2022.116896 more frequently.
2022-08-24
4.17 submitted; 5.10 minor revisions after initial review; 5.22 revised; 6.22 accepted. There were some minor mistakes during the editing process, which delayed the acceptance time by about a week. Overall, the review process was relatively fast and the editor was very nice. The data requirements are comprehensive, and it is one of the more prestigious journals in the field of medicinal chemistry. We hope that the impact factor (IF) for the year 2022 can increase.
2022-06-28

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started